

Medical oncologist/co-author of the most influential modern interpretation of hormone therapy safety.
Why this matters: This work critically re-evaluates earlier interpretations of hormone therapy risks, and highlights the importance of timing, individualized care, and updated evidence in women’s health.

Hormone Therapy Position Statements
Most effective treatment for vasomotor symptoms
Benefits outweigh risks for most women <60 or within 10 years of menopause
Transdermal estrogen may reduce clot risk
Menopause Clinical Practice Guideline
Recommends hormone therapy for moderate–severe symptoms
Emphasizes individualized risk assessment
Supports transdermal estrogen in higher-risk patients
Papers, Recommendations, Statements
Confirms hormone therapy as most effective treatment
Encourages individualized care
Genitourinary Syndrome of Menopause (GSM) Guideline
Supports low-dose vaginal estrogen
Improves urinary + vaginal symptoms
Minimal systemic absorption
Female Sexual Health & Testosterone Therapy Publications
Supports testosterone for Hypoactive Sexual Desire Disorder (HSDD)
Recommends physiologic dosing
Emphasizes sexual health as essential
Initial data raised concern about risks
Later analysis supports importance of timing
Outcomes vary based on patient age and therapy type
Early estrogen → improved vascular outcomes
Supports timing hypothesis
Reduced atherosclerosis progression
Early hormone therapy shows neutral/beneficial cardiovascular impact
No increased cardiovascular risk in early menopause
Supports lower-dose/transdermal use
A large, multi-site U.S. study following over 3,300 women through the menopause transition.
Tracks perimenopause changes
Shows symptom variability
Identifies metabolic shifts
Reduced cardiovascular disease and mortality
No increased breast cancer risk
Supports early initiation of hormone therapy
Oral estrogen increases risk of venous thromboembolism (VTE), while transdermal estrogen does not.
Micronized progesterone appears neutral in clot risk compared to some synthetic progestins.


Areas of ongoing research and evolving evidence:
Brain health and menopause
Thyroid dysfunction in women
Testosterone therapy in women
Low-dose vaginal estrogen safety
Bone and muscle health in midlife
Perimenopause and metabolic health
Cardiovascular protection & estrogen timing

Current clinical research
Evidence-based guidelines
Functional medicine principles
Individualized optimized patient care